Biomarkers in Hepatocellular Carcinoma: Diagnosis, Prognosis and Treatment Response Assessment.
Piñero F, Dirchwolf M, Pessôa MG. · 2020
Read Biomarkers in Hepatocellular Carcinoma: Diagnosis, Prognosis and Treatment Response Assessment. by Piñero F, Dirchwolf M, Pessôa MG. (2020) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7349517.txt.
Description
Piñero and co-authors present a review in Cells on biomarkers for liver cancer. The cancer at issue is hepatocellular carcinoma, a leading cause of cancer death worldwide. The review asks what blood and tissue markers can do in care today. It covers screening, diagnosis, outlook, and response to treatment.
The authors find that current serum markers miss too many early cases to guide screening well. Uneven cut-off points across studies add to the problem. Markers look more promising for judging outlook and for picking or checking treatments. One marker, alpha-fetoprotein, already helps select some therapies. Newer fields such as proteomics and genomics may yield better tools. Readers get a sober map of where these tests help now and where they still fall short.
Catalog record
| CREATOR | Piñero F, Dirchwolf M, Pessôa MG. |
|---|---|
| YEAR | 2020 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 104 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |